Bosentan for the treatment of pulmonary arterial hypertensionKENYON, Kenneth W; NAPPI, Jean M.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1055-1062, issn 1060-0280, 8 p.Article

Cor pulmonale in cystic fibrosisECKLES, Michael; ANDERSON, Paula.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 323-330, issn 1069-3424, 8 p.Article

Cardiovascular abnormalities in sleep-disordered breathingJUDD, Brooke G; LIU, Stephen; SATEIA, Michael J et al.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 315-321, issn 1069-3424, 7 p.Article

Chronic thromboembolic pulmonary hypertensionFEDULLO, Peter F; AUGER, William R; KERR, Kim M et al.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 273-285, issn 1069-3424, 13 p.Article

Classification of acute respiratory disorders of all newborns in a tertiary care centerAGRAWAL, Vish; DAVID, Richard J; HARRIS, Vivian J et al.Journal of the National Medical Association. 2003, Vol 95, Num 7, pp 585-595, issn 0027-9684, 11 p.Article

Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertensionFIRTH, Amy L; WEIJUAN YAO; OGAWA, Aiko et al.American journal of physiology. Cell physiology. 2010, Vol 67, Num 5, issn 0363-6143, C1217-C1225Article

Primary pulmonary hypertension: current updateRICH, S; BRUNDAGE, B. H.JAMA, the journal of the American Medical Association. 1984, Vol 251, Num 17, pp 2252-2254, issn 0098-7484Article

Unexplained severe pulmonary hypertension in the older age groupPHIPPS, B; WONG, B; CHANG, C. H. J et al.Chest. 1983, Vol 84, Num 4, pp 399-402, issn 0012-3692Article

Survival with first-line bosentan in patients with primary pulmonary hypertensionMCLAUGHLIN, V. V; SITBON, O; BADESCH, D. B et al.The European respiratory journal. 2005, Vol 25, Num 2, pp 244-249, issn 0903-1936, 6 p.Article

Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertensionKATO, T; KITAMURA, H; KANISAWA, M et al.Experimental and molecular pathology. 1989, Vol 50, Num 3, pp 305-315, issn 0014-4800, 11 p.Article

Pulmonary hypertension in pediatric patientsPERKIN, R. M; ANAS, N. G.The Journal of pediatrics. 1984, Vol 105, Num 4, pp 511-522, issn 0022-3476Article

Proceedings of national heart, lung, and blood institute pediatric cardiology workshop: pulmonary hypertensionFRIEDMAN, W. F.Pediatric research. 1986, Vol 20, Num 9, pp 811-824, issn 0031-3998Article

Medical therapy for pulmonary arterial hypertension: ACCP Evidence-based clinical practice guidelinesBADESCH, David B; ABMAN, Steve H; AHEARN, Gregory S et al.Chest. 2004, Vol 126, Num 1, pp S35-S62, issn 0012-3692, SUPArticle

Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literatureBARTYIK, Katalin; BEDE, Olga; TISZLAVICZ, Laszlo et al.European journal of pediatrics. 2004, Vol 163, Num 12, pp 731-737, issn 0340-6199, 7 p.Article

S-nitrosothiol signaling in respiratory biologyGASTON, Benjamin; SINGEL, David; DOCTOR, Allan et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 11, pp 1186-1193, issn 1073-449X, 8 p.Article

Bosentan therapy for portopulmonary hypertensionHOEPER, M. M; HALANK, M; MARX, C et al.The European respiratory journal. 2005, Vol 25, Num 3, pp 502-508, issn 0903-1936, 7 p.Article

Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanismSHAH, Mehul; PATEL, Kirit; SEHGAL, Pravin B et al.American journal of physiology. Cell physiology. 2005, Vol 57, Num 4, pp C850-C862, issn 0363-6143Article

Predicting survival in pulmonary arterial hypertension in the UKLEE, Wai-Ting Nicola; YI LING; SHEARES, Karen K et al.The European respiratory journal. 2012, Vol 40, Num 3, pp 604-611, issn 0903-1936, 8 p.Article

Proteomic Analysis of Lung Tissues From Patients With Pulmonary Arterial HypertensionABDUL-SALAM, Vahitha B; WHARTON, John; CUPITT, John et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 20, pp 2058-2067, issn 0009-7322, 10 p.Article

Use of assisted reproductive technologies and anesthesia in a patient with primary pulmonary hypertensionMETZLER, Elise; GINSBURG, Elizabeth; TSEN, Lawrence C et al.Fertility and sterility. 2004, Vol 81, Num 6, pp 1684-1687, issn 0015-0282, 4 p.Article

Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertensionYEAGER, Michael E; COLVIN, Kelley L; EVERETT, Allen D et al.Proteomics. Clinical applications (Print). 2012, Vol 6, Num 5-6, pp 257-267, issn 1862-8346, 11 p.Article

The acute administration of vasodilators in primary pulmonary hypertension: Experience from the national institutes of health registry on primary pulmonary hypertensionWEIR, E. K; RUBIN, L. J; KERNIS, J. T et al.The American review of respiratory disease. 1989, Vol 140, Num 6, pp 1623-1630, issn 0003-0805Article

Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonistsSTANBROOK, H. S; MORRIS, K. G; MCMURTRY, I. F et al.The American review of respiratory disease. 1984, Vol 130, Num 1, pp 81-85, issn 0003-0805Article

Vasodilator therapy for primary pulmonary hypertensionMCGOON, M. D; VLIETSTRA, R. E.Mayo Clinic proceedings. 1984, Vol 59, Num 10, pp 672-677, issn 0025-6196Article

QUANTITATIVE EVALUATION OF HYPERTENSIVE PULMONARY ARTERIAL CHANGEYAMAKI S; TEZUKA F.1979; ACTA PATHOL. JAP.; JPN; DA. 1979; VOL. 29; NO 1; PP. 61-66; BIBL. 8 REF.Article